Navigation Links
Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
Date:11/6/2008

WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc., (Amex: ILI), announced today that it will host a conference call and webcast on Thursday, November 13, 2008, at 4:30 pm EST to review the Company's third quarter 2008 financial results and provide an update on recent corporate developments.

To access the live call, dial 877-675-4756 (domestic) or 719-325-4902 (international). The live webcast and replay access of the teleconference will be available on the Investors section of the Company's website at http://www.ilgenetics.com.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics has developed and commercialized genetic tests for risk assessment of coronary artery disease, periodontal disease, and general nutrition. The Company currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics and its ongoing programs,
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
2. Interleukin-12 indicates survival prospects for melanoma patients
3. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
4. Interleukin Genetics Reports Fourth Quarter and Year End 2007 Financial Results
5. T cell immunity enhanced by timing of interleukin-7 therapy
6. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
7. Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
8. Penn scientists map molecular regulation of fat-cell genetics
9. DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results
10. Genetics, Environment Shape Sexual Behavior
11. Homosexual behavior due to genetics and environmental factors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...re-USNewswire/ -- The American Public Health Assoc... provisions in the health reform bill passed last ...ll, the House takes important steps toward univers...s and moving our health system from one that focus...ping people healthy," said Georges C. Benjamin, MD...
(Date:11/8/2009)...s Nail Nation,s Job Creators ,, WASHINGTON, Nov... House passage of the health care bill (H.R. 3962)...BE Council) president & CEO Karen Kerrigan iss...ke, those voting for H.R. 3962 voted to burden our...ing taxes and penalties. Even in the best of econo...
(Date:11/8/2009)...ing of biopharmaceuticals to be available at the C... Toronto, ON (PRWEB) Novemb... Therapure Biopharma Inc. today announced that the...pharmaceutical grade freeze dryer and expects to m...) available for contract manufacturing of biopharm...
(Date:11/8/2009)...ispanic health advocates committed to achieving me...TON, Nov. 7 "Tonight th...eard the voice of America,s families by passing th...Senate must deliver, without delay, on the promise...L. Delgado, President and CEO of the National Alli...
(Date:11/8/2009)... Health Care Reform Bill ,, Critical legislat...r all Americans ,, CHICAGO, Nov. 7 /PRNewswire...Representatives passed by a vote of 220-215, criti...ngthen Medicare for seniors and end discrimination...ericans out of affordable health coverage. ,,...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...Va., May 16 CEL-SCI CORPORATION,(Amex: CVM ) rep...s ended,March 31, 2008., Geert Kersten, Chief Exe...e completely focused on getting our cancer therapy...ng facility for,Multikine from which we can supply...
... Clinical Functionality and Innovative Clinical To...formance, LAS VEGAS, May 16 Vital Images, Inc. (...de advanced visualization and,analysis solutions f...th Annual Workstation Face-Off, highlighted,the br...
...ILL, N.C., May 16 Superior launch strategies,allo... as a leader in,crowded markets. To secure "share ...elop specific uptake strategies to support busines...oduct,s,success., "Best Practices for Winning Pro...
... to Visit Omaha to Rally Residents to Eat Right, M...ir Diets, OMAHA, Neb., May 16 The last decade ca... diets -- which seem to go in and out of,fashion l...in overweight or obese., A new campaign crossing ...
...e expands natural killer cells in cord blood more ... News) A treatment that uses natural killer (NK) ...ctively destroys human leukemia cells in mice, res... test mice with aggressive human leukemias, accord...
... following news tips are based on abstracts or pos...rican Society of Clinical Oncology (ASCO) to be he... Study Tracks a Biomarker for Early Detection of ... NYU Cancer Institutes Harvey Pass, M.D., professo...
Other Medicine News:Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 2Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 3Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 4Health News:CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 5Health News:Vital Images Showcases the ViTAL Enterprise Solution at Stanford University's 6th Annual Face-Off 2Health News:Vital Images Showcases the ViTAL Enterprise Solution at Stanford University's 6th Annual Face-Off 3Health News:Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Nebraska Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:New Therapy Kills Human Leukemia Cells in Mice 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4
(Date:11/6/2009)...PRNewswire/ -- Repossessions and liquidations of t...uarter of 2009 declined as compared to similar fig...nt,s NasTrac Quarterly Index (NQI). The figures, ...h repossessions and orderly liquidations, also ind...on and printing equipment, offering mixed news on ...
(Date:11/6/2009)...ire-FirstCall/ -- Caraco Pharmaceutical Laboratori... tromethamine ophthalmic solution, 0.5% following ...tration (FDA) for Sun Pharma,s Abbreviated New Dru...halmic solution on the first day following patent ...tically equivalent to Acular® Ophthalmic Solu...
(Date:11/6/2009)...wswire-USNewswire/ -- America,s Specialty Medicine...id-market and smaller innovator pharmaceutical com...the "Affordable Health Care for America Act," intr...aller companies fear that the cumulative effect of...ir efforts to bring new medicines to market. ,...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Rep Boustany Hauled in 241 25 Million From Health and Insurance Industry 56670 1Rep Boustany Hauled in 241 25 Million From Health and Insurance Industry 56670 2Stryker To Host Conference Call on October 20 2009 56668 1Stryker To Host Conference Call on October 20 2009 56668 2Wed Sept 16 11 AM News Conference 3A Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Cele 56666 1Wed Sept 16 11 AM News Conference 3A Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Cele 56666 2
Creatine Kinase Kinetic Reagent
Creatine Kinase-MB (CK-MB)
Magnesium
Glucose UV Liquidplus
Medicine Products: